FAIR's Recommended Research Allocation Policies
1. A disease’s mortality rate shall be given emphasis in determining allocations. Secondary factors, as listed below, shall then apply to insure appropriate funding levels for all illnesses.
2. The research allocations shall be determined by consensus of medical experts and individual disease representatives from both within and outside of the NIH.
Secondary Allocation Factors
3. The degree of disability and suffering caused by a disease or condition.
4. The rate of incidence of a disease: morbidity.
5. The degree to which a disease cuts short a normal, productive, comfortable lifetime.
6. The economic and social costs of a disease.
7. The need to act quickly to stop the spread of a disease (e.g., a plague spread by airborne transmission).
8. The degree of preventability of a disease.
9. If a disease is a rare or "orphan disease." (An orphan disease is a rare illness which has not been "adopted" by the pharmaceutical industry because it provides little financial incentive for the private sector to make and market new medications to treat or prevent it.)
10. The degree to which a disease is heavily responsible for deaths, but is frequently not reported on the death certificate.